URL: http://www.nature.com/cgi-taf/DynaPage.taf?file=/nature/journal/v409/n6820/full/409549a0_fs.html
Date accessed: 25 February 2001
Nature 409, 549 (2001) © Macmillan Publishers Ltd.
01 February 2001
DAVID SPURGEON
[MONTREAL] The newly created Canadian Institutes of
Health Research (CIHR) has signalled in its first round of funding that it will
keep its promise to support "innovative interdisciplinary ways to conduct
research". The agency announced last week that it will distribute Can$64 million (US$43
million) across nearly 500 diverse research projects, involving some 600
researchers in 100 different institutions. The CIHR's budget over the next three years is effectively twice that of the
Medical Research Council of Canada, which the CIHR replaced last June (Nature
405, 722; 2000) — and the new agency considerably broadens the
scope of health research in Canada. Many of the projects are on a scale that Canadian researchers have not
previously enjoyed. Nineteen Interdisciplinary Health Research Teams (IHRTs),
comprising more than 500 investigators in 91 institutes across Canada and
internationally, will share Can$15.5 million. These teams will undertake research projects on such topics as the process of
ageing; opiate addiction; breast-cancer susceptibility; and a genetic,
epidemiological and population-based approach to the impact and control of
colorectal cancer. A further 19 large-scale multidisciplinary projects have been funded under
the Community Alliances for Health Research (CAHR) programme, which aims to
foster excellence in research of relevance to community groups and agencies in
biomedical and clinical research, and in health services generally. These
projects will include research into community genetics, women's unpaid
care-giving, chronic illness in rural healthcare systems, and marine and coastal
workplace health and safety. Funds were also approved for clinical trials, equipment and maintenance
grants. Pilot projects in the national Genomics Research Program include a
project at the University of Toronto to develop a rapid 'gene-trapping' method.
Research grants are also being awarded under the federal government's HIV/AIDS
strategy and the Health Canada/CIHR research initiative on hepatitis C. Robert S. Bell, an IHRT recipient at Mount Sinai Hospital, Toronto, says the
programme has given himself and his colleagues "a unique opportunity"
to bring together the three major centres in Canada for musculoskeletal cancers,
and to combine clinical information with basic biology.
Stand and deliver: awards will make Canada 'the place to be' for
health research, says Bernstein. In a message to Canadian researchers, CIHR president Alan Bernstein said the
awards demonstrate the CIHR's commitment to transform research in Canada. "If we establish the right balance between investigator-initiated and
strategic research, along with the right process to develop the right
initiatives," said Bernstein, "I am convinced that we will be able to
create [an] environment that will make Canada 'the place to be' for health
research in the twenty-first century."
Before the CIHR was set up, says Bell, "there was no agency that would
allow us to bring together patient information, tumour specimens, basic science
information, clinical information and clinical outcomes and put that together
into a big database that lets us to go from the patient to the laboratory and
back again."
CIHR
Category: 19. General Patent and/or Biotechnology Information